By Catherine Eckford (European Pharmaceutical Review)2024-05-30T17:10:39
The unique system offers a targeted approach to deliver cancer drugs to tumours while helping to limit negative side effects.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-04-29T14:00:00Z 2026-04-29T15:00:00Z
Sponsored by USP
2026-06-10T15:00:00Z 2026-06-10T16:00:00Z
Sponsored by BioDuro
2026-04-14T12:32:00Z
Sponsored by Thermo Fisher Scientific
2026-04-14T12:29:00Z
Sponsored by JRS Pharma, In association with Vetter Pharma
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-02-09T10:00:00 2026-02-09T11:00:00
Sponsored by Emerson
2026-05-13T14:00:00 2026-05-13T15:00:00
Sponsored by Thermo Fisher Scientific
2025-07-25T08:10:00
Sponsored by JRS Pharma and Gattefosse, By European Pharmaceutical Review
2025-12-11T13:32:00
Sponsored by Hexagon
Site powered by Webvision Cloud